Detalhe da pesquisa
1.
The agreement between bronchoalveolar lavage, bronchial wash and sputum culture: a retrospective study.
Infection
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589747
2.
Clinical Relevance of Rifampicin-Moxifloxacin Interaction in Isoniazid-Resistant/Intolerant Tuberculosis Patients.
Antimicrob Agents Chemother
; 66(2): e0182921, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807758
3.
Population Pharmacokinetic Modelling and Limited Sampling Strategies for Therapeutic Drug Monitoring of Pyrazinamide in Patients with Tuberculosis.
Antimicrob Agents Chemother
; 66(7): e0000322, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727060
4.
Towards elimination of childhood and adolescent tuberculosis in the Netherlands: an epidemiological time-series analysis of national surveillance data.
Eur Respir J
; 56(4)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32471938
5.
Retraction Note: Infection of great apes and a zoo keeper with the same Mycobacterium tuberculosis spoligotype.
Med Microbiol Immunol
; 209(6): 705, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32648095
6.
Corticosteroid therapy for the management of paradoxical inflammatory reaction in patients with pulmonary tuberculosis.
Infection
; 48(4): 641-645, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333368
7.
Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31010868
8.
Evaluation of Carbapenems for Treatment of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 63(2)2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455232
9.
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Lancet
; 392(10150): 821-834, 2018 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30215381
10.
Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands.
Eur Respir J
; 54(6)2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515410
11.
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.
Eur Respir J
; 54(6)2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601711
12.
Performance of a web-based application measuring spot quality in dried blood spot sampling.
Clin Chem Lab Med
; 57(12): 1846-1853, 2019 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31373896
13.
Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment.
Clin Infect Dis
; 67(suppl_3): S327-S335, 2018 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30496467
14.
Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment.
Clin Infect Dis
; 67(suppl_3): S303-S307, 2018 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30496466
15.
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.
N Engl J Med
; 382(24): 2376-2377, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32521142
16.
Systematic Review of Salivary Versus Blood Concentrations of Antituberculosis Drugs and Their Potential for Salivary Therapeutic Drug Monitoring.
Ther Drug Monit
; 40(1): 17-37, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29120971
17.
Combining digital adherence technology and therapeutic drug monitoring for personalised tuberculosis care.
Eur Respir J
; 60(6)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356974
18.
Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis.
Eur Respir J
; 47(4): 1229-34, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26743484
19.
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
Eur Respir J
; 47(4): 1235-43, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26965290
20.
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
Eur Respir J
; 47(6): 1758-66, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27076583